Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Pixium Vision S.A. logo — Innovating at the frontier of neuroscience : brain machine i...

Pixium Vision S.A.

Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons !

Founded 2011 France France 13 employees Post Ipo Equity Total: $33.30M Health Care, Information Technology +1

General Information

Company Name Pixium Vision S.A.
Founded Year 2011
Location France France +1
Employees 13
Industries Health Care, Information Technology, Medical Devices
Funding Stage Post Ipo Equity
Social

Get notified when Pixium Vision S.A. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pixium Vision S.A.

Pixium Vision S.A. is a pioneer in the field of neuroscience, focusing on brain-machine interfacing to restore vision for individuals with retinal degeneration. The company has developed two innovative Bionic Vision Systems, PRIMA (Subretinal) and IRIS®II (Epiretinal), aimed at compensating for vision loss and blindness from conditions such as Dry Age-Related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP). These systems leverage state-of-the-art biomedical and bioelectronic technologies, along with smart bio-inspired algorithms and AI, to enable minimal invasive retinal surgery and provide blind individuals with a form of prosthetic bionic vision. Founded in 2011, Pixium Vision has made significant strides in the field of neuromodulation technology, aiming to restore a form of prosthetic vision. The company went public on the Euronext Paris stock exchange in 2014 and has continued to collaborate with renowned scientific and clinical partners, including Institut de la Vision Paris, Stanford University California, Moorfields Eye Hospital London, and Institute of Ocular Microsurgery (IMO) Barcelona. Notably, the company received a €7.30M post-IPO equity investment on 15 July 2020 from Bpifrance and Sofinnova Partners, demonstrating confidence in its innovative vision restoration technology. With its groundbreaking approach and strategic collaborations, Pixium Vision is poised to make a significant impact in the healthcare and medical devices industries, particularly for individuals with vision loss.

Taxonomy: Bionic Vision Systems, Neuroscience, Neuromodulation, Bioelectronics, Artificial Vision, Retinal Implant Systems, Neuro-Ophthalmology, Bioelectronic Technologies, Digital Medicine, Retinitis Pigmentosa, Age-Related Macular Degeneration (AMD), Sensory Neuromodulation, Neurobiological Research, Bioelectronic Medicine, Neuro-Ophthalmic Implants

Services & Products

Development and commercialization of medical devices for ophthalmic applications

Target Customers

Healthcare institutions ophthalmologists patients with macular degeneration

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 2
Investor Investor
15 Jul 2020
Post-IPO Debt •••••• 1
Investor
29 Sep 2016
Series A •••••• 5
Investor Investor Investor Investor
•••• •••• 		25 Nov 2013
Venture Round •••••• 1
Investor
01 Jan 2012

Pixium Vision S.A. Alternatives & Competitors

Pixium Vision S.A. vs
VISION CARE CENTER LIMITED
VISION CARE CENTER LIMITED

Enhancing Quality of Life Through Advanced Vision Solutions

Series Unknown
2 employees
Health Care, Medical Devices

FAQ About Pixium Vision S.A.

Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons !
Pixium Vision S.A. was founded in 2011.
Pixium Vision S.A. is headquartered in France.
Pixium Vision S.A. operates in the following industries: Health Care, Information Technology, Medical Devices.
Pixium Vision S.A. has approximately 13 employees.
Pixium Vision S.A. has completed 4 funding rounds, raising a total of $33.30M. The latest funding stage is Post Ipo Equity.
Pixium Vision S.A. offers: Development and commercialization of medical devices for ophthalmic applications.
Top alternatives and competitors to Pixium Vision S.A. include VISION CARE CENTER LIMITED. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pixium Vision S.A. and VISION CARE CENTER LIMITED are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pixium Vision S.A. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy